drugset / Trial / NCT00137007
Zithromax EV in Community-Acquired Pneumonia (CAP)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The intravenous (IV) regimen containing azithromycin (Zithromax) plus ampicillin-sulbactam is consistent with current guidelines for the treatment of CAP. In fact the International guidelines for the treatment of CAP in hospitalised patients suggests the use of a combination between a b-lactam and a macrolide. This trial will allow investigators to evaluate the efficacy of azithromycin plus ampicillin-sulbactam in the treatment of hospitalized subjects with community acquired pneumonia. In addition, this trial will allow investigators to evaluate the safety and toleration of combination therapy.
Timeline
- Start
- 2003-11
- Primary completion
- —
- Completion
- 2005-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ampicillin/sulbactam | Small molecule | — | Intravenous |
| Subject | Azithromycin | Small molecule | — | Intravenous |